Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration

Journal of Urology

Volumn 182, Issue 3, 2009, Pages 900-906

  Hellenthal, Nicholas J ⁱ   Shariat, Shahrokh F ^d   Margulis, Vitaly ^c   Karakiewicz, Pierre I ^l   Roscigno, Marco ^a   Bolenz, Christian ^d,h   Remzi, Mesut ^e   Weizer, Alon ^g   Zigeuner, Richard ^b   Bensalah, Karim ^m   Ng, Casey K ^j   Raman, Jay D ^j   Kikuchi, Eiji ^f   Montorsi, Francesco ^e   Oya, Mototsugu ^f   Wood, Christopher G ^c   Fernandez, Mario ^k   Evans, Christopher P ⁱ   Koppie, Theresa M ⁱ  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF MICHIGAN   (United States)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Department of Obstetrics Gynecology   (United States)

^k UNIVERSIDAD DEL DESARROLLO   (Chile)

^l UNIVERSITÉ DE MONTRÉAL   (Canada)

^m UNIVERSITÉ DE RENNES 1   (France)

more..

Author keywords

adjuvant; carcinoma; chemotherapy; kidney; mortality; transitional cell; ureter

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROGNOSIS; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; SURVIVAL ANALYSIS; URETERAL NEOPLASMS;

EID: 68149171763     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.05.011     Document Type: Article

References (20)

1. Raman J.D., and Scherr D.S. Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol 4 (2007) 432
2. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (1998) 594
3. Sternberg C.N., Yagoda A., Scher H.I., et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 64 (1989) 2448
4. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859
5. Lehmann J., Retz M., Wiemers C., et al. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). J Clin Oncol 23 (2005) 4963
6. Tannock I., Gospodarowicz M., Connolly J., et al. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience. J Urol 142 (1989) 289
7. Huben R.P., Mounzer A.M., and Murphy G.P. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62 (1988) 2016
8. Charbit L., Gendreau M.C., Mee S., et al. Tumors of the upper urinary tract: 10 years of experience. J Urol 146 (1991) 1243
9. Lee S.H., Lin J.S., Tzai T.S., et al. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract. Eur Urol 29 (1996) 266
10. Igawa M., Urakami S., Shiina H., et al. Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract. Urol Int 55 (1995) 74
11. Bolenz C., Fernández M.I., Trojan L., et al. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Urology 72 (2008) 364
12. Lee S.E., Byun S.S., Park Y.H., et al. Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract. Urol Int 77 (2006) 22
13. Kwak C., Lee S.E., Jeong I.G., et al. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68 (2006) 53
14. Michael M., Tannock I.F., Czaykowski P.M., et al. Adjuvant chemotherapy for high-risk urothelial transitional cell carcinoma: the Princess Margaret Hospital experience. Br J Urol 82 (1998) 366
15. Bamias A., Deliveliotis C., Fountzilas G., et al. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 22 (2004) 2150
16. Huang W.C., Sevey A.S., Serio A.M., et al. Chronic renal disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncology 7 (2006) 735
17. Hochster H.S., Luo W., Popa E.C., et al. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299. J Clin Oncol 25 (2007) 5397
18. Langer C., Li S., Schiller J., et al. Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599. J Clin Oncol 25 (2007) 418
19. Kang C.H., Yu T.J., Hsieh H.H., et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98 (2003) 1620
20. Novara G., De Marco V., Gottardo F., et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110 (2007) 1715